All lobbying filings

LEAVITT PARTNERS, LLC

Lobbying for ALLIANCE FOR MRNA MEDICINES · Multi-organization alliance representing the MRNA sector.

Filing Q2 amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

ROBERT CLAYTON ALSPACH

Previously held: Chief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C, Clerk - E&C, and Paid Intern - E&C
SARA SINGLETON

Previously held: Deputy Assistant Secretary-HHS; Policy Advisor- Senate; Legislative Assistant- Senate; Policy Fellow- Senate

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

The Alliance for mRNA Medicines (AMM) is dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.